NEW YORK (GenomeWeb News) – WaferGen Biosystems reported after the close of the market on Thursday a 55 percent jump in its fourth quarter revenues.

For the three months ended Dec. 31, 2013, total revenues reached $490,465, up from $316,177 in the prior-year fourth quarter. Product revenues increased to $365,465, compared to $316,177 a year ago, while license and royalty revenues in Q4 2013 were $125,000, compared to zero a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.